News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LipidViro Tech, Inc. (LVRO) to Present at Financial Services Exchange Investment Conference to Discuss Potential for New Treatment for Stroke and Chronic Heart Failure


4/27/2007 2:05:55 PM

SALT LAKE CITY, UT -- (MARKET WIRE) -- April 27, 2007 -- LipidViro Tech, Inc. (OTCBB: LPVT), a medical device company developing its proprietary d-OSAB technology for the treatment of stroke and chronic heart failure, announced that J.S. Latino, co-founder and head of research, and Linda Sharkus, Ph.D., director, are attending the Financial Services Exchange (FSX) Investment Conference being held April 26-28, 2007, at the Hilton San Francisco Financial District Hotel in San Francisco.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES